Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY. (2026). Frontier in Medical and Health Research, 4(3), 4636-4645. https://fmhr.net/index.php/fmhr/article/view/3855